Abstract:Objectives/hypothesis: Death-associated protein kinase (DAPK) is a Ca/calmodulin-regulated Ser/Thr kinase that functions as a positive mediator of programmed cell death. It has been found that DAPK gene is frequently inactivated by its promoter hypermethylation in some cancers and tumor cell lines. However, it is not clear whether promoter hypermethylation of DAPK gene exists in laryngeal squamous cell cancer (LSCC). The aim of this study was to investigate the promoter methylation status of the DAPK gene in LSCC and the effect of 5-Aza-2'-deoxycytidine (5-Aza-CdR), a demethylating agent, on Hep-2 cells, a human laryngeal cancer cell line, and on xenografts of Hep-2. Methods: Methylation-specific polymerase chain reaction (PCR) and reverse-transcription PCR techniques were used to determine the promoter methylation status and mRNA expression of DAPK gene in LSCC. Furthermore, Hep-2 cells in vitro and in vivo were treated by 5-Aza-CdR to explore the effect of demethylating agents on DAPK mRNA expression and tumor growth. Results: Hypermethylation of DAPK gene promoter was found in 39 (67.2%) of 58 LSCC samples. There was no significant difference in the promoter hypermethylation rate among the samples of different histologic grades or samples from patients with different T stages. However, there was significant difference in methylation status of DAPK gene between the samples from patients in N0 stages and those from patients in N1 stages. No promoter hypermethylation of DAPK gene was found in any of the five normal laryngeal tissue samples. DAPK mRNA expression was not detected in tumor specimens with promoter hypermethylation. On the contrary, DAPK mRNA expression was observed in the unmethylated tumor specimens, specimens from tissues adjacent to the tumor, and normal laryngeal tissues samples. Promoter hypermethylation of DAPK gene was found, and no DAPK mRNA expression was detected in Hep-2 cells. DAPK mRNA expression in Hep-2 cells and xenografts could be restored by treating cells and xenografts with 5-Aza-CdR. The tumors' xenografts, induced by way of Hep-2 cell injection in nude mice treated with 5-Aza-CdR, were obviously smaller than those in nude mice treated with phosphate-buffered saline. Conclusions: Abnormal loss of DAPK expression could be associated with aberrant promoter region methylation in the LSCC. 5-Aza-CdR may slow the growth of Hep-2 cells in vitro and in vivo by reactivating tumor suppressor gene DAPK silenced by de novo methylation.

Methylation and Protein Expression of Death-Associated Protein Kinase Gene in Oral Squamous Cell Carcinoma

Hypermethylation of GSTP1 and DAPK gene in prostate cancer

Mrna Expression and Hypermethylation of Tumor Suppressor Genes Apoptosis Protease Activating Factor-1 and Death-Associated Protein Kinase in Oral Squamous Cell Carcinoma.

Methylation of Apoptotic Protease Activating Factor 1 in Oral Squamous Cell Carcinoma

Detection of aberrant methylation of RARβ2, GSTP1 and DAPK gene in prostate cancer and its clinical significance

DAPK Promoter Hypermethylation in Tissues and Body Fluids of Oral Precancer Patients

The promoter methylation of death-associated protein kinase influences expressions of its mRNA and protein in tissue of gastric cancer

Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.

The detection of the death-associated protein kinase in oral squamous cell carcinoma by Semiquantitative RT-PCR

[Hypermethylation of the Death-Associated Protein Kinase Promoter in Laryngeal Squamous Cell Cancer].

Aberrant Methylation Of Death-Associated Protein Kinase 1 Cpg Islands In Myelodysplastic Syndromes

Aberrant Methylation and Expression of Dapk1 in Human Hypopharyngeal Squamous Cell Carcinoma

Epigenetic Regulation of Death-Associated Protein Kinase Expression in Primary Gastric Cancers from Chinese Patients

An Integrated Methylation and Gene Expression Microarray Analysis Reveals Significant Prognostic Biomarkers in Oral Squamous Cell Carcinoma

Analysis of Promoter Hypermethylation of Death-Asscciated Protein Kinase Gene in Blood from Non-Small Cell Lung Cancer Patients

Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer

Study on Methylation of CpG Island in the Promoter Region of DAPK Gene in Gastric Cancer

Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis

Expression and Biological Significance of SOCS3 and SOCS3 DNA Methylation in Oral Squamous Cell Carcinoma(OSCC)

Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma

Identification Of Differentially Expressed Genes Induced By Aberrant Methylation In Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis